Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-06-28
2008-07-29
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S398000, C546S192000, C546S330000, C548S335100
Reexamination Certificate
active
07405229
ABSTRACT:
This invention relates to a class of compounds having the general formula (I) which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
REFERENCES:
patent: 6313117 (2001-11-01), Bekkali et al.
patent: WO 01/96285 (2001-12-01), None
patent: WO 02/069901 (2002-09-01), None
patent: WO 03/041649 (2003-05-01), None
Obach R.S., Drug-drug interactions; An important negative attribute in Drugs. Drugs of Today, 39(5), 301-38, 2003.
Bayly Christopher
Black Cameron
Crane Sheldon
McKay Daniel J.
Oballa Renata
Beeler Nicole M.
Coppins Janet L
Merck Frosst Canada & Co.
Muthard David A.
Saeed Kamal
LandOfFree
Cathepsin cysteine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cathepsin cysteine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cathepsin cysteine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3963745